NDC 0220-0109

Aethusa cynapium

Aethusa Cynapium

Aethusa cynapium is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Boiron. The primary component is Aethusa Cynapium.

Product ID0220-0109_84b31246-1ed7-7ef7-e053-2a91aa0a6bfb
NDC0220-0109
Product TypeHuman Otc Drug
Proprietary NameAethusa cynapium
Generic NameAethusa Cynapium
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date1983-03-03
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameBoiron
Substance NameAETHUSA CYNAPIUM
Active Ingredient Strength200 [kp_C]/200[kp_C]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0220-0109-41

200 [kp_C] in 1 TUBE (0220-0109-41)
Marketing Start Date1983-03-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0220-0109-41 [00220010941]

Aethusa cynapium PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date1983-03-03

Drug Details

Active Ingredients

IngredientStrength
AETHUSA CYNAPIUM200 [kp_C]/200[kp_C]

OpenFDA Data

SPL SET ID:84b31246-1ed6-7ef7-e053-2a91aa0a6bfb
Manufacturer
UNII

NDC Crossover Matching brand name "Aethusa cynapium" or generic name "Aethusa Cynapium"

NDCBrand NameGeneric Name
0220-0104Aethusa cynapiumAETHUSA CYNAPIUM
0220-0105Aethusa cynapiumAETHUSA CYNAPIUM
0220-0109Aethusa cynapiumAETHUSA CYNAPIUM
15631-0009AETHUSA CYNAPIUMAETHUSA CYNAPIUM
60512-6450AETHUSA CYNAPIUMAETHUSA CYNAPIUM
62106-7220AETHUSA CYNAPIUMFools parsley
63545-067Aethusa cynapiumAethusa cynapium
63545-761Aethusa cynapiumAethusa cynapium
63545-762Aethusa cynapiumAethusa cynapium
63545-763Aethusa cynapiumAethusa cynapium
63545-764Aethusa cynapiumAethusa cynapium
63545-765Aethusa cynapiumAethusa cynapium
63545-766Aethusa cynapiumAethusa cynapium
66096-780Aethusa CynapiumAETHUSA CYNAPIUM
68428-183Aethusa CynapiumAethusa Cynapium
71919-018Aethusa cynapiumAethusa cynapium
64117-102Vomiting DiarrheaAETHUSA CYNAPIUM

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.